We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Innovation in Cancer, Infectious Disease Research

News   Jan 20, 2017 | Original story from UC Berkeley

 
Innovation in Cancer, Infectious Disease Research

Stephen Isaacs, CEO of Aduro Biotech, at the launch of the IVRI on March 23. (Peg Skorpinski photos)

 
 
 

RELATED ARTICLES

Vitamin D Metabolites Influence T Cell Priming

News

Fresh insights on the effect of vitamin D on the immune system add to the greater picture of how vitamin D might influence susceptibility to inflammatory diseases.

READ MORE

CRISPR Treats Lethal Lung Disease Before Birth in Animal Model

News

Using CRISPR gene editing, a team from Children's Hospital of Philadelphia (CHOP) and Penn Medicine have thwarted a lethal lung disease in an animal model in which a harmful mutation causes death within hours after birth.

READ MORE

HIV Suppressed for up to Four Months by Novel Antibody

News

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE